| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| X4 Pharmaceuticals, Inc | Chief Commercial Officer | Common Stock | 25.3K | $62.9K | $2.48 | May 16, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | May 16, 2025 | 1 | $2.56K | 4/A | Jun 3, 2025 | Chief Commercial Officer |
| XFOR | X4 Pharmaceuticals, Inc | Jan 23, 2025 | 2 | -$13.2K | 4 | Jan 27, 2025 | Chief Commercial Officer |
| XFOR | X4 Pharmaceuticals, Inc | Oct 4, 2024 | 2 | -$6.51K | 4 | Oct 8, 2024 | Chief Commercial Officer |
| XFOR | X4 Pharmaceuticals, Inc | May 17, 2024 | 3 | $19.3K | 4 | Feb 14, 2025 | Chief Commercial Officer |
| XFOR | X4 Pharmaceuticals, Inc | Feb 13, 2024 | 1 | $0 | 4 | Feb 16, 2024 | Chief Commercial Officer |
| XFOR | X4 Pharmaceuticals, Inc | Nov 1, 2023 | 1 | -$7.49K | 4 | Nov 3, 2023 | Chief Commercial Officer |
| XFOR | X4 Pharmaceuticals, Inc | Oct 31, 2023 | 1 | $0 | 4 | Nov 2, 2023 | Chief Commercial Officer |
| XFOR | X4 Pharmaceuticals, Inc | Nov 3, 2022 | 1 | $644K | 4 | Nov 4, 2022 | Chief Commercial Officer |
| XFOR | X4 Pharmaceuticals, Inc | Nov 3, 2022 | 0 | $0 | 3 | Nov 4, 2022 | Chief Commercial Officer |